Research ArticleCancer

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

See allHide authors and affiliations

Science Translational Medicine  06 Jan 2021:
Vol. 13, Issue 575, eabb6295
DOI: 10.1126/scitranslmed.abb6295

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine